Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters
|
July 24, 2012
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Journal of Medicinal Chemistry
|
June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
European Journal of Medicinal Chemistry
|
February 26, 2019
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
Sonia Martínez-González, Sonsoles Rodríguez-Arístegui, Cristina Ana Gómez de la Oliva, et al.
European Journal of Medicinal Chemistry
|
December 29, 2023
Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)
Cédric Couturier, Quentin Ronzon, Giulia Lattanzi, et al.
Hepatology (Baltimore, Md.)
|
July 18, 2018
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Marina Bárcena-Varela, Stefano Caruso, Susana Llerena, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 24, 2012
Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Nature Medicine
|
July 5, 2019
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Cristina Segovia, Edurne San José-Enériz, Ester Munera-Maravilla, et al.
Nature Communications
|
July 2, 2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, et al.
Nature Communications
|
May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
Journal of Cheminformatics
|
March 27, 2015
The CHEMDNER corpus of chemicals and drugs and its annotation principles
Martin Krallinger, Obdulia Rabal, Florian Leitner, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters
|
July 24, 2012
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Journal of Medicinal Chemistry
|
June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
European Journal of Medicinal Chemistry
|
February 26, 2019
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
Sonia Martínez-González, Sonsoles Rodríguez-Arístegui, Cristina Ana Gómez de la Oliva, et al.
European Journal of Medicinal Chemistry
|
December 29, 2023
Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)
Cédric Couturier, Quentin Ronzon, Giulia Lattanzi, et al.
Hepatology (Baltimore, Md.)
|
July 18, 2018
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Marina Bárcena-Varela, Stefano Caruso, Susana Llerena, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 24, 2012
Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Nature Medicine
|
July 5, 2019
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Cristina Segovia, Edurne San José-Enériz, Ester Munera-Maravilla, et al.
Nature Communications
|
July 2, 2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, et al.
Nature Communications
|
May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
Journal of Cheminformatics
|
March 27, 2015
The CHEMDNER corpus of chemicals and drugs and its annotation principles
Martin Krallinger, Obdulia Rabal, Florian Leitner, et al.
Page
of 6